About
H42 Inc develops epigenetic clocks and related diagnostic kits that measure biological age and disease signatures from a single assay, with applications in rheumatoid arthritis, colorectal cancer screening, and skin aging.
Explore H42 Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.